4.7 Article

A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis

Maxime Espi et al.

Summary: Patients on maintenance hemodialysis (MHD) show weakened immune responses after receiving two doses of mRNA vaccine, but those with a history of COVID-19 may benefit from a third vaccine injection based on their stronger response to the vaccine.

KIDNEY INTERNATIONAL (2021)

Article Urology & Nephrology

Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis

Ayelet Grupper et al.

Summary: Patients on maintenance hemodialysis showed a significantly lower humoral response following the BNT162b2 vaccine compared to the control group, with age being an important factor in the humoral response.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Letter Urology & Nephrology

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine

Vivette D. D'Agati et al.

KIDNEY INTERNATIONAL (2021)

Article Urology & Nephrology

Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2

Claudius Speer et al.

Summary: Patients receiving long-term hemodialysis show a reduced antibody response to the first and second doses of the mRNA vaccine BNT162b2. The majority (82%) develop neutralizing antibodies after the second dose but at lower levels than healthy controls.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Urology & Nephrology

Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients

Dominique Bertrand et al.

Summary: Immunization with BNT162b2 appears to be more effective in HDPs, with the immune response in KTRs potentially influenced by immunosuppressive medications. Current vaccinal strategies for KTRs may not provide adequate protection against COVID-19 and may need further improvement.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Urology & Nephrology

Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients

Clement Danthu et al.

Summary: The study shows that kidney transplant recipients have a strong inhibition of humoral response to COVID-19 vaccination due to immunosuppressant therapy, while patients undergoing hemodialysis have lower antibody levels. Factors such as age, serum albumin, and Kt/V can impact the level of antibody response.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Letter Urology & Nephrology

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine

Christophe Masset et al.

KIDNEY INTERNATIONAL (2021)

Article Immunology

Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients

Hector Rincon-Arevalo et al.

Summary: Patients with kidney failure are at increased risk for SARS-CoV-2 infection, making effective vaccination critical. However, studies have found significantly impaired antibody responses to the BNT162b2 vaccine in kidney transplant recipients and dialysis patients, leading to insufficient immune responses.

SCIENCE IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Article Urology & Nephrology

Outcomes of patients with end -stage kidney disease hospitalized with COVID-19

Jia H. Ng et al.

KIDNEY INTERNATIONAL (2020)

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

Article Transplantation

COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration

Luuk B. Hilbrands et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)

Review Urology & Nephrology

Immune cell dysfunction and inflammation in end-stage renal disease

Michiel G. H. Betjes

NATURE REVIEWS NEPHROLOGY (2013)

Article Transplantation

The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France

C Couchoud et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)